Read more about the article FDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria
FDA Issues New Draft Guidances On Cancer Clinical Trial Eligibility Criteria

FDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria

The FDA recently unveiled the draft guidance for the industry titled, “Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.” This draft guidance serves as a framework for maintaining the highest standards of data integrity in clinical and bioanalytical domains, crucial for supporting investigational new drug applications, new drug applications, and abbreviated new drug applications.

Continue ReadingFDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria
Read more about the article Exploring the Evolving Landscape of Ophthalmology Clinical Development
Leading CRO for Ophthalmology clinical development - clinical trials

Exploring the Evolving Landscape of Ophthalmology Clinical Development

Few fields in clinical research are as dynamic and promising as ophthalmology. With the global population ageing and eye diseases becoming more prevalent, there is a growing demand for innovative treatments and therapies. This blog explores the emerging trends and updates that are shaping the ophthalmology clinical development landscape.

Continue ReadingExploring the Evolving Landscape of Ophthalmology Clinical Development
Read more about the article Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies
Ensuring Data Integrity: FDA's Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

The FDA recently unveiled the draft guidance for the industry titled, “Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.” This draft guidance serves as a framework for maintaining the highest standards of data integrity in clinical and bioanalytical domains, crucial for supporting investigational new drug applications, new drug applications, and abbreviated new drug applications.

Continue ReadingEnsuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies
Read more about the article FDA and Clinical Trials: Ensuring Safety and Efficacy
FDA and Clinical Trials - Ensuring Safety and Efficacy - Lambda CRO

FDA and Clinical Trials: Ensuring Safety and Efficacy

FDA and Clinical Trials: Clinical trials stand as the cornerstone of pharmaceutical and biotech advancements, enabling new treatments and therapies to reach patients worldwide. At the helm of this transformative…

Continue ReadingFDA and Clinical Trials: Ensuring Safety and Efficacy